Quote For SkyePharma PLC SKP.L

SkyePharma PLC (SKP.L) (London Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  27 Nov 2009
92.00GBp
Price Change
+1.25
Percent Change
+1.38%
 
Research a stock:   symbol lookup
92.00p
27 Nov 2009
+1.38%
90.75p
94.00p
16,576
94.00p
92.00p
191.00p
74.75p
0.44
22,855

News

Press Releases

Flutiform EU Clinical Trial Successfully Completed
Monday, 2 Nov 2009(MarketWire) 
Skyepharma PLC announces Conversion of Bonds
Monday, 22 Jun 2009(MarketWire) 
Skyepharma PLC announces Conversion of Bonds
Monday, 22 Jun 2009(MarketWire) 

Key Developments

Officers

Name Current Position Compensation
Condella, Frank Non-Executive Chairman of the Board 633,000
Cunningham, Kenneth Chief Executive Officer, Executive Director 575,000
Grant, Peter Chief Financial Officer, Executive Director 439,000

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) £22.03
Shares Outstanding (Mil.) 23.94
Float (Mil.) 23.80
Dividend Information
Yield % --
Annual Dividend (£ GBP) 0.00
Payout Ratio(TTM) % --
Financial Strength
Quick Ratio 1.36
Current Ratio 1.11
LT Debt/Equity --
Total Debt/Equity --
Valuation Ratios
Price/Earnings(TTM) --
Price/Sales(TTM) 0.37
Price/Book(TTM) --
Price/Cash Flow(TTM) --
Per Share Data
Earnings(TTM) £-1.72
Sales(TTM) £3.13
Book Value(MRQ) £-3.40
Cash Flow(TTM) £-1.23
Cash(MRQ) £0.92
Management Effectiveness
Return on Equity(TTM) --
Return on Assets(TTM) -29.08
Return on Investment(TTM) -49.96
Margins
Gross Margin(TTM) % 71.33
Operating Margin(TTM) % -12.14
Profit Margin(TTM) % -47.22

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement